NRX Pharmaceuticals Inc (NRXP)

[TurdBlossom]

I am invested in both commons and warrants at about 25% commons and 75% warrants. Only time will tell whether it was wiser to add more commons or warrants but I chose to add more commons last week because we likely saw the last opportunity to add commons in the 11s. I plan to hold all the commons long (+3 years) as I hope to see bigger gains but over a longer period of time (company product development/ revenue + long cap gains tax).
The leverage of warrants should provide a higher return. My impression is that the warrants will be called as soon as possible (condition: SP > $18 for 21 of 30 days) because one reason the management chose to use BRPA as a SPAC was due to the high insider ownership. If so then the warrants may not be around long enough to benefit from inhaled Aviptadil let alone dry powder pocket puff inhalers, the Brilife vaccine platform, long-hauler COVID therapy, other non-COVID pulmonary conditions, or the depression med. Warrants did not track commons when NRXP was BRPA however the float was a ridiculously micro at the time. My gut tells me maybe I should’ve gone with more warrants to sell for commons but the die has been cast. My opinion. GLTA